Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -143.97% is 20% above its 5-year average of -181.04%, near the high end of its 5-year range (-1376.21%–7.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 241.97% below its 12-month average of -42.10%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -143.97%.
RETURN ON INVESTED CAPITAL (ROIC)
-143.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-60.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-181.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-171.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-241.97%
CURRENT VS 3Y AVG
-139.50%
CURRENT VS 5Y AVG
+20.47%
CURRENT VS 10Y AVG
+15.88%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 680 covered companies
CURRENT VS SECTOR MEDIAN
-318.10%
vs the sector median at left
LifeMD, Inc.
Market Cap
$134.69M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-42.10%
3Y Avg
-60.11%
5Y Avg
-181.04%
Market Cap
$136.21M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.42M
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-23.12%
3Y Avg
-29.64%
5Y Avg
-23.50%
Market Cap
$132.74M
Return on Invested Capital (ROIC)
-0.98%
TTM Avg
-12.17%
3Y Avg
-37.42%
5Y Avg
-26.70%
Market Cap
$137.16M
Return on Invested Capital (ROIC)
-314.66%
TTM Avg
-92.03%
3Y Avg
-77.08%
5Y Avg
-89.09%
Market Cap
$131.16M
Return on Invested Capital (ROIC)
-21.42%
TTM Avg
-8.92%
3Y Avg
-14.86%
5Y Avg
-16.42%
Market Cap
$139.28M
Return on Invested Capital (ROIC)
-7.01%
TTM Avg
-1.96%
3Y Avg
-0.91%
5Y Avg
1.75%
Market Cap
$139.63M
Return on Invested Capital (ROIC)
-50.04%
TTM Avg
-28.33%
3Y Avg
-324.90%
5Y Avg
-237.35%
Market Cap
$139.73M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMD) | $134.69M | -143.97% | -42.10% | -60.11% | -181.04% |
| Freenome, Inc. (FRNM)vs › | $136.21M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.42M | -7.95% | -23.12% | -29.64% | -23.50% |
| Organigram Global Inc. (OGI)vs › | $132.74M | -0.98% | -12.17% | -37.42% | -26.70% |
| Pyxis Oncology, Inc. (PYXS)vs › | $137.16M | -314.66% | -92.03% | -77.08% | -89.09% |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | -21.42% | -8.92% | -14.86% | -16.42% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $139.28M | -7.01% | -1.96% | -0.91% | 1.75% |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | -50.04% | -28.33% | -324.90% | -237.35% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -10.85% | -101.00% | -120.85% | -96.47% |
| Entera Bio Ltd. (ENTX)vs › | $127.91M | -82.87% | -100.14% | -98.73% | -97.80% |
ROIC
-144.0%
ROE
-266.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -143.97% |
| 2026-03-31 | -62.82% |
| 2025-12-31 | -4.96% |
| 2025-09-30 | 7.35% |
| 2025-06-30 | -6.10% |
| 2025-03-31 | -27.71% |
| 2024-12-31 | -74.84% |
| 2024-09-30 | -98.72% |
| 2024-06-30 | -103.78% |
| 2024-03-31 | -85.39% |
| 2023-12-31 | -60.31% |
| 2023-09-30 | -263.97% |
| 2023-06-30 | -539.97% |
| 2023-03-31 | -382.69% |
| 2022-09-30 | -554.71% |
| 2022-06-30 | -431.94% |
| 2022-03-31 | -224.28% |
| 2021-12-31 | -199.92% |
| 2021-06-30 | -1376.21% |
| 2021-03-31 | -1710.94% |
| 2019-12-31 | -1012.22% |
| 2019-09-30 | -1092.70% |
| 2019-06-30 | -2123.53% |
| 2019-03-31 | -299.35% |
| 2018-12-31 | -123.04% |
| 2018-09-30 | -125.80% |
| 2018-06-30 | -96.71% |
| 2018-03-31 | -109.55% |
| 2017-12-31 | -135.08% |
| 2017-09-30 | -248.08% |
| 2016-09-30 | -109.84% |
| 2016-06-30 | -115.19% |
| 2016-03-31 | -123.20% |
| 2015-12-31 | -93.32% |
| 2014-09-30 | -1238.08% |
| 2014-06-30 | -1189.86% |
| 2014-03-31 | -477.36% |
| 2013-12-31 | -205.35% |
| 2013-09-30 | -448.66% |
| 2013-06-30 | -173.13% |
| 2013-03-31 | -351.00% |
| 2012-12-31 | -295.74% |
